ICD-10 Coding for Screening PSA(Z12.5, R97.20)
Complete ICD-10-CM coding and documentation guide for Screening PSA. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Screening PSA
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| Z12.5 | Encounter for screening for malignant neoplasm of prostate | Use for asymptomatic patients undergoing routine prostate cancer screening. |
|
| R97.20 | Elevated prostate specific antigen [PSA] | Use when PSA levels are elevated and the patient is asymptomatic. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for screening PSA
Essential facts and insights about Screening PSA
Primary ICD-10-CM Codes for screening psa
Decision Criteria
clinical Criteria
- Patient is asymptomatic and presents for routine screening.
documentation Criteria
- Documentation includes 'routine screening' and 'no symptoms'.
Applicable To
- Routine prostate cancer screening
Excludes
- Screening with symptoms
Clinical Validation Requirements
- Patient is asymptomatic
- Routine screening documented
Code-Specific Risks
- Incorrect use with symptomatic patients
Coding Notes
- Ensure documentation states 'asymptomatic' and 'routine screening'.
R97.20 - Elevated prostate specific antigen [PSA]
Use when PSA levels are elevated and the patient is asymptomatic.
Applicable To
- Elevated PSA without symptoms
Excludes
- Routine screening
Clinical Validation Requirements
- PSA level above normal range
- No symptoms documented
Coding Notes
Ensure PSA level is documented as elevated.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Family history of malignant neoplasm of prostate
Z80.42Differential Codes
Alternative codes to consider when ruling out similar conditions to the primary diagnosis.
Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Screening PSA to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code Z12.5.
Impact
Clinical: Incomplete patient history, Regulatory: Potential audit risk, Financial: Possible claim denial
Mitigation Strategy
Always ask about family history, Document any relevant family history
Impact
Reimbursement: Claims may be denied if symptoms are present., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate patient records.
Mitigation Strategy
Use appropriate codes for symptoms and elevated PSA.
Impact
Using Z12.5 for patients with symptoms
Mitigation Strategy
Verify patient symptoms before coding
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Screening PSA, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Screening PSA
Use these documentation templates to ensure complete and accurate documentation for Screening PSA. These templates include all required elements for proper coding and billing.
Routine Screening
Specialty: Primary CareRequired Elements
- Chief Complaint
- HPI
- Family History
- Assessment/Plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Screening PSA? Ask your questions below.